Brevel sprouts $18.5M to develop microalgae-based alternative proteins

Microalgae is everywhere, it seems. It’s being used as a way to replace fossil fuels and is used in cosmetics and pharmaceuticals and as a food source. It’s a substantial market, too, expected to be valued at $25.4 billion by 2033.
Brevel, a Tel Aviv–based company, is developing microalgae into an alternative protein and today announced $18.5 million in seed funding.
Founded in 2016 by three brothers, Yonatan Golan, Matan Golan and Ido Golan, Brevel developed a proprietary technology that combines fermentation and light to make a protein from microalgae that is sold to food companies as a powd

リンク元